10 20 30 40 50 60 70 80 1JPP - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER CELL ADHESION 02-AUG-01 1JPP
TITLE THE STRUCTURE OF A BETA-CATENIN BINDING REPEAT FROM ADENOMATOUS TITLE 2 POLYPOSIS COLI (APC) IN COMPLEX WITH BETA-CATENIN
COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-CATENIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ADENOMATOUS POLYPOSIS COLI PROTEIN; COMPND 7 CHAIN: C, D; COMPND 8 SYNONYM: APC PROTEIN; COMPND 9 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX-2T; SOURCE 10 MOL_ID: 2; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 13 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMAN).
KEYWDS DISEASE MUTATION, ANTI-ONCOGENE, CELL ADHESION
EXPDTA X-RAY DIFFRACTION
AUTHOR K.E.SPINK,S.G.FRIDMAN,W.I.WEIS
REVDAT 4 13-JUL-11 1JPP 1 VERSN REVDAT 3 24-FEB-09 1JPP 1 VERSN REVDAT 2 01-APR-03 1JPP 1 JRNL REVDAT 1 16-JAN-02 1JPP 0
JRNL AUTH K.EKLOF SPINK,S.G.FRIDMAN,W.I.WEIS JRNL TITL MOLECULAR MECHANISMS OF BETA-CATENIN RECOGNITION BY JRNL TITL 2 ADENOMATOUS POLYPOSIS COLI REVEALED BY THE STRUCTURE OF AN JRNL TITL 3 APC-BETA-CATENIN COMPLEX. JRNL REF EMBO J. V. 20 6203 2001 JRNL REFN ISSN 0261-4189 JRNL PMID 11707392 JRNL DOI 10.1093/EMBOJ/20.22.6203
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.H.HUBER,W.I.WEIS REMARK 1 TITL THE STRUCTURE OF THE BETA-CATENIN/E-CADHERIN COMPLEX AND THE REMARK 1 TITL 2 MOLECULAR BASIS OF DIVERSE LIGAND RECOGNITION BY REMARK 1 TITL 3 BETA-CATENIN REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 105 391 2001 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/S0092-8674(01)00330-0 REMARK 1 REFERENCE 2 REMARK 1 AUTH T.A.GRAHAM,C.WEAVER,F.MAO,D.KIMELMAN,W.XU REMARK 1 TITL CRYSTAL STRUCTURE OF A BETA-CATENIN/TCF COMPLEX REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 103 885 2000 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/S0092-8674(00)00192-6 REMARK 1 REFERENCE 3 REMARK 1 AUTH A.H.HUBER,W.J.NELSON,W.I.WEIS REMARK 1 TITL THREE-DIMENSIONAL STRUCTURE OF THE ARMADILLO REPEAT REGION REMARK 1 TITL 2 OF BETA-CATENIN REMARK 1 REF CELL(CAMBRIDGE,MASS.) V. 90 871 1997 REMARK 1 REFN ISSN 0092-8674 REMARK 1 DOI 10.1016/S0092-8674(00)80352-9
REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.27 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1211274.610 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 86.1 REMARK 3 NUMBER OF REFLECTIONS : 18919 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.274 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 971 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.009 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.21 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 77.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1613 REMARK 3 BIN R VALUE (WORKING SET) : 0.3470 REMARK 3 BIN FREE R VALUE : 0.3940 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 107 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.038 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7772 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 6 REMARK 3 SOLVENT ATOMS : 72 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 51.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.81000 REMARK 3 B22 (A**2) : 8.52000 REMARK 3 B33 (A**2) : 0.29000 REMARK 3 B12 (A**2) : 1.12000 REMARK 3 B13 (A**2) : 0.44000 REMARK 3 B23 (A**2) : 3.59000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.40 REMARK 3 ESD FROM SIGMAA (A) : 0.65 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.51 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.83 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.79 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.170 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.060 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.990 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.960 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.32 REMARK 3 BSOL : 50.50 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1JPP COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-AUG-01. REMARK 100 THE RCSB ID CODE IS RCSB014041.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAR-01 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : CURVED CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19916 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 28.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.7 REMARK 200 DATA REDUNDANCY : 1.470 REMARK 200 R MERGE (I) : 0.08200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 87.8 REMARK 200 DATA REDUNDANCY IN SHELL : 1.39 REMARK 200 R MERGE FOR SHELL (I) : 0.24200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1G3J REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.23 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, SODIUM POTASSIUM PHOSPHATE, REMARK 280 SODIUM CHLORIDE, DTT, PH 6.2, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 134 REMARK 465 ALA A 135 REMARK 465 VAL A 136 REMARK 465 VAL A 137 REMARK 465 ASN A 138 REMARK 465 LEU A 139 REMARK 465 ILE A 140 REMARK 465 ASN A 141 REMARK 465 TYR A 142 REMARK 465 GLN A 143 REMARK 465 ASP A 144 REMARK 465 ASP A 145 REMARK 465 ALA A 146 REMARK 465 GLU A 147 REMARK 465 LEU A 148 REMARK 465 ALA A 149 REMARK 465 THR A 150 REMARK 465 THR A 547 REMARK 465 GLN A 548 REMARK 465 ARG A 549 REMARK 465 ARG A 550 REMARK 465 THR A 551 REMARK 465 SER A 552 REMARK 465 MET A 553 REMARK 465 GLY A 554 REMARK 465 GLY A 555 REMARK 465 THR A 556 REMARK 465 GLN A 557 REMARK 465 GLN A 558 REMARK 465 GLN A 559 REMARK 465 PHE A 560 REMARK 465 GLU A 664 REMARK 465 ASP A 665 REMARK 465 LYS A 666 REMARK 465 PRO A 667 REMARK 465 GLN A 668 REMARK 465 ASP A 669 REMARK 465 TYR A 670 REMARK 465 LYS A 671 REMARK 465 HIS B 134 REMARK 465 ALA B 135 REMARK 465 VAL B 136 REMARK 465 VAL B 137 REMARK 465 ASN B 138 REMARK 465 LEU B 139 REMARK 465 ILE B 140 REMARK 465 ASN B 141 REMARK 465 TYR B 142 REMARK 465 GLN B 143 REMARK 465 ASP B 144 REMARK 465 ASP B 145 REMARK 465 ALA B 146 REMARK 465 GLU B 147 REMARK 465 LEU B 148 REMARK 465 ALA B 149 REMARK 465 ASP B 546 REMARK 465 THR B 547 REMARK 465 GLN B 548 REMARK 465 ARG B 549 REMARK 465 ARG B 550 REMARK 465 THR B 551 REMARK 465 SER B 552 REMARK 465 MET B 553 REMARK 465 GLY B 554 REMARK 465 GLY B 555 REMARK 465 THR B 556 REMARK 465 GLN B 557 REMARK 465 GLU B 664 REMARK 465 ASP B 665 REMARK 465 LYS B 666 REMARK 465 PRO B 667 REMARK 465 GLN B 668 REMARK 465 ASP B 669 REMARK 465 TYR B 670 REMARK 465 LYS B 671 REMARK 465 SER C 1032 REMARK 465 ASP C 1033 REMARK 465 GLU C 1034 REMARK 465 GLN C 1035 REMARK 465 GLN D 1035
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 181 CG CD CE NZ REMARK 470 ARG A 225 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 642 CG CD OE1 OE2 REMARK 470 THR B 150 OG1 CG2 REMARK 470 ARG B 151 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 170 CG CD CE NZ REMARK 470 HIS B 224 CG ND1 CD2 CE1 NE2 REMARK 470 ARG B 225 CG CD NE CZ NH1 NH2 REMARK 470 CYS B 350 SG REMARK 470 GLU B 359 CG CD OE1 OE2 REMARK 470 PHE B 560 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLU B 629 CG CD OE1 OE2 REMARK 470 LYS C1030 CG CD CE NZ REMARK 470 LYS D1030 CG CD CE NZ REMARK 470 ASP D1033 CG OD1 OD2
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO C1024 C - N - CA ANGL. DEV. = 10.4 DEGREES REMARK 500 PRO D1024 C - N - CA ANGL. DEV. = 9.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 161 79.94 -157.38 REMARK 500 ASP A 162 -86.74 -88.95 REMARK 500 GLU A 163 -32.36 -176.01 REMARK 500 VAL A 166 -35.24 -36.23 REMARK 500 ARG A 190 18.76 -61.06 REMARK 500 PRO A 192 -3.11 -52.83 REMARK 500 ALA A 255 -65.03 -28.22 REMARK 500 THR A 330 -44.79 -139.02 REMARK 500 SER A 389 -50.44 -26.39 REMARK 500 THR A 393 12.66 -67.09 REMARK 500 LEU A 408 3.59 -68.28 REMARK 500 ASN A 430 29.09 43.97 REMARK 500 THR A 472 46.55 -90.17 REMARK 500 SER A 473 135.97 -170.11 REMARK 500 HIS A 475 162.40 170.67 REMARK 500 LEU A 487 -0.48 -58.63 REMARK 500 SER A 502 151.63 -22.33 REMARK 500 ALA A 522 -4.61 -56.65 REMARK 500 GLU A 562 -7.30 69.89 REMARK 500 ALA A 581 8.43 -59.59 REMARK 500 LYS A 625 -70.83 -25.79 REMARK 500 MET A 662 46.20 -87.49 REMARK 500 ASN B 161 55.89 -107.52 REMARK 500 ASP B 162 -163.53 -116.73 REMARK 500 GLN B 165 31.58 -80.58 REMARK 500 SER B 179 -6.64 -56.19 REMARK 500 ARG B 190 25.34 -62.66 REMARK 500 PRO B 192 -11.20 -47.97 REMARK 500 GLN B 193 -67.76 -95.67 REMARK 500 LEU B 244 5.43 -69.51 REMARK 500 LEU B 286 7.30 -65.14 REMARK 500 ASN B 308 102.34 178.60 REMARK 500 THR B 330 -41.23 -134.98 REMARK 500 LEU B 382 -70.72 -66.59 REMARK 500 TRP B 383 -77.42 -25.78 REMARK 500 THR B 384 -54.97 -28.70 REMARK 500 ASP B 390 8.17 -66.80 REMARK 500 ALA B 391 19.34 -145.62 REMARK 500 THR B 393 15.31 -67.05 REMARK 500 THR B 472 49.15 -90.49 REMARK 500 SER B 473 141.40 -170.17 REMARK 500 HIS B 475 165.74 176.82 REMARK 500 LEU B 487 -3.12 -59.85 REMARK 500 ALA B 522 -3.19 -53.58 REMARK 500 GLN B 559 72.63 43.45 REMARK 500 PHE B 560 63.53 -107.04 REMARK 500 GLU B 562 3.82 56.10 REMARK 500 ALA B 581 5.73 -64.66 REMARK 500 LYS B 625 -71.55 -23.92 REMARK 500 GLU B 649 -9.57 -50.33 REMARK 500 REMARK 500 THIS ENTRY HAS 56 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 PRO A 500 45.5 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 672
DBREF 1JPP A 134 671 UNP Q02248 CTNB1_MOUSE 134 671 DBREF 1JPP B 134 671 UNP Q02248 CTNB1_MOUSE 134 671 DBREF 1JPP C 1021 1035 UNP P25054 APC_HUMAN 1021 1035 DBREF 1JPP D 1021 1035 UNP P25054 APC_HUMAN 1021 1035
SEQRES 1 A 538 HIS ALA VAL VAL ASN LEU ILE ASN TYR GLN ASP ASP ALA SEQRES 2 A 538 GLU LEU ALA THR ARG ALA ILE PRO GLU LEU THR LYS LEU SEQRES 3 A 538 LEU ASN ASP GLU ASP GLN VAL VAL VAL ASN LYS ALA ALA SEQRES 4 A 538 VAL MET VAL HIS GLN LEU SER LYS LYS GLU ALA SER ARG SEQRES 5 A 538 HIS ALA ILE MET ARG SER PRO GLN MET VAL SER ALA ILE SEQRES 6 A 538 VAL ARG THR MET GLN ASN THR ASN ASP VAL GLU THR ALA SEQRES 7 A 538 ARG CYS THR ALA GLY THR LEU HIS ASN LEU SER HIS HIS SEQRES 8 A 538 ARG GLU GLY LEU LEU ALA ILE PHE LYS SER GLY GLY ILE SEQRES 9 A 538 PRO ALA LEU VAL LYS MET LEU GLY SER PRO VAL ASP SER SEQRES 10 A 538 VAL LEU PHE TYR ALA ILE THR THR LEU HIS ASN LEU LEU SEQRES 11 A 538 LEU HIS GLN GLU GLY ALA LYS MET ALA VAL ARG LEU ALA SEQRES 12 A 538 GLY GLY LEU GLN LYS MET VAL ALA LEU LEU ASN LYS THR SEQRES 13 A 538 ASN VAL LYS PHE LEU ALA ILE THR THR ASP CYS LEU GLN SEQRES 14 A 538 ILE LEU ALA TYR GLY ASN GLN GLU SER LYS LEU ILE ILE SEQRES 15 A 538 LEU ALA SER GLY GLY PRO GLN ALA LEU VAL ASN ILE MET SEQRES 16 A 538 ARG THR TYR THR TYR GLU LYS LEU LEU TRP THR THR SER SEQRES 17 A 538 ARG VAL LEU LYS VAL LEU SER VAL CYS SER SER ASN LYS SEQRES 18 A 538 PRO ALA ILE VAL GLU ALA GLY GLY MET GLN ALA LEU GLY SEQRES 19 A 538 LEU HIS LEU THR ASP PRO SER GLN ARG LEU VAL GLN ASN SEQRES 20 A 538 CYS LEU TRP THR LEU ARG ASN LEU SER ASP ALA ALA THR SEQRES 21 A 538 LYS GLN GLU GLY MET GLU GLY LEU LEU GLY THR LEU VAL SEQRES 22 A 538 GLN LEU LEU GLY SER ASP ASP ILE ASN VAL VAL THR CYS SEQRES 23 A 538 ALA ALA GLY ILE LEU SER ASN LEU THR CYS ASN ASN TYR SEQRES 24 A 538 LYS ASN LYS MET MET VAL CYS GLN VAL GLY GLY ILE GLU SEQRES 25 A 538 ALA LEU VAL ARG THR VAL LEU ARG ALA GLY ASP ARG GLU SEQRES 26 A 538 ASP ILE THR GLU PRO ALA ILE CYS ALA LEU ARG HIS LEU SEQRES 27 A 538 THR SER ARG HIS GLN GLU ALA GLU MET ALA GLN ASN ALA SEQRES 28 A 538 VAL ARG LEU HIS TYR GLY LEU PRO VAL VAL VAL LYS LEU SEQRES 29 A 538 LEU HIS PRO PRO SER HIS TRP PRO LEU ILE LYS ALA THR SEQRES 30 A 538 VAL GLY LEU ILE ARG ASN LEU ALA LEU CYS PRO ALA ASN SEQRES 31 A 538 HIS ALA PRO LEU ARG GLU GLN GLY ALA ILE PRO ARG LEU SEQRES 32 A 538 VAL GLN LEU LEU VAL ARG ALA HIS GLN ASP THR GLN ARG SEQRES 33 A 538 ARG THR SER MET GLY GLY THR GLN GLN GLN PHE VAL GLU SEQRES 34 A 538 GLY VAL ARG MET GLU GLU ILE VAL GLU GLY CYS THR GLY SEQRES 35 A 538 ALA LEU HIS ILE LEU ALA ARG ASP VAL HIS ASN ARG ILE SEQRES 36 A 538 VAL ILE ARG GLY LEU ASN THR ILE PRO LEU PHE VAL GLN SEQRES 37 A 538 LEU LEU TYR SER PRO ILE GLU ASN ILE GLN ARG VAL ALA SEQRES 38 A 538 ALA GLY VAL LEU CYS GLU LEU ALA GLN ASP LYS GLU ALA SEQRES 39 A 538 ALA GLU ALA ILE GLU ALA GLU GLY ALA THR ALA PRO LEU SEQRES 40 A 538 THR GLU LEU LEU HIS SER ARG ASN GLU GLY VAL ALA THR SEQRES 41 A 538 TYR ALA ALA ALA VAL LEU PHE ARG MET SER GLU ASP LYS SEQRES 42 A 538 PRO GLN ASP TYR LYS SEQRES 1 B 538 HIS ALA VAL VAL ASN LEU ILE ASN TYR GLN ASP ASP ALA SEQRES 2 B 538 GLU LEU ALA THR ARG ALA ILE PRO GLU LEU THR LYS LEU SEQRES 3 B 538 LEU ASN ASP GLU ASP GLN VAL VAL VAL ASN LYS ALA ALA SEQRES 4 B 538 VAL MET VAL HIS GLN LEU SER LYS LYS GLU ALA SER ARG SEQRES 5 B 538 HIS ALA ILE MET ARG SER PRO GLN MET VAL SER ALA ILE SEQRES 6 B 538 VAL ARG THR MET GLN ASN THR ASN ASP VAL GLU THR ALA SEQRES 7 B 538 ARG CYS THR ALA GLY THR LEU HIS ASN LEU SER HIS HIS SEQRES 8 B 538 ARG GLU GLY LEU LEU ALA ILE PHE LYS SER GLY GLY ILE SEQRES 9 B 538 PRO ALA LEU VAL LYS MET LEU GLY SER PRO VAL ASP SER SEQRES 10 B 538 VAL LEU PHE TYR ALA ILE THR THR LEU HIS ASN LEU LEU SEQRES 11 B 538 LEU HIS GLN GLU GLY ALA LYS MET ALA VAL ARG LEU ALA SEQRES 12 B 538 GLY GLY LEU GLN LYS MET VAL ALA LEU LEU ASN LYS THR SEQRES 13 B 538 ASN VAL LYS PHE LEU ALA ILE THR THR ASP CYS LEU GLN SEQRES 14 B 538 ILE LEU ALA TYR GLY ASN GLN GLU SER LYS LEU ILE ILE SEQRES 15 B 538 LEU ALA SER GLY GLY PRO GLN ALA LEU VAL ASN ILE MET SEQRES 16 B 538 ARG THR TYR THR TYR GLU LYS LEU LEU TRP THR THR SER SEQRES 17 B 538 ARG VAL LEU LYS VAL LEU SER VAL CYS SER SER ASN LYS SEQRES 18 B 538 PRO ALA ILE VAL GLU ALA GLY GLY MET GLN ALA LEU GLY SEQRES 19 B 538 LEU HIS LEU THR ASP PRO SER GLN ARG LEU VAL GLN ASN SEQRES 20 B 538 CYS LEU TRP THR LEU ARG ASN LEU SER ASP ALA ALA THR SEQRES 21 B 538 LYS GLN GLU GLY MET GLU GLY LEU LEU GLY THR LEU VAL SEQRES 22 B 538 GLN LEU LEU GLY SER ASP ASP ILE ASN VAL VAL THR CYS SEQRES 23 B 538 ALA ALA GLY ILE LEU SER ASN LEU THR CYS ASN ASN TYR SEQRES 24 B 538 LYS ASN LYS MET MET VAL CYS GLN VAL GLY GLY ILE GLU SEQRES 25 B 538 ALA LEU VAL ARG THR VAL LEU ARG ALA GLY ASP ARG GLU SEQRES 26 B 538 ASP ILE THR GLU PRO ALA ILE CYS ALA LEU ARG HIS LEU SEQRES 27 B 538 THR SER ARG HIS GLN GLU ALA GLU MET ALA GLN ASN ALA SEQRES 28 B 538 VAL ARG LEU HIS TYR GLY LEU PRO VAL VAL VAL LYS LEU SEQRES 29 B 538 LEU HIS PRO PRO SER HIS TRP PRO LEU ILE LYS ALA THR SEQRES 30 B 538 VAL GLY LEU ILE ARG ASN LEU ALA LEU CYS PRO ALA ASN SEQRES 31 B 538 HIS ALA PRO LEU ARG GLU GLN GLY ALA ILE PRO ARG LEU SEQRES 32 B 538 VAL GLN LEU LEU VAL ARG ALA HIS GLN ASP THR GLN ARG SEQRES 33 B 538 ARG THR SER MET GLY GLY THR GLN GLN GLN PHE VAL GLU SEQRES 34 B 538 GLY VAL ARG MET GLU GLU ILE VAL GLU GLY CYS THR GLY SEQRES 35 B 538 ALA LEU HIS ILE LEU ALA ARG ASP VAL HIS ASN ARG ILE SEQRES 36 B 538 VAL ILE ARG GLY LEU ASN THR ILE PRO LEU PHE VAL GLN SEQRES 37 B 538 LEU LEU TYR SER PRO ILE GLU ASN ILE GLN ARG VAL ALA SEQRES 38 B 538 ALA GLY VAL LEU CYS GLU LEU ALA GLN ASP LYS GLU ALA SEQRES 39 B 538 ALA GLU ALA ILE GLU ALA GLU GLY ALA THR ALA PRO LEU SEQRES 40 B 538 THR GLU LEU LEU HIS SER ARG ASN GLU GLY VAL ALA THR SEQRES 41 B 538 TYR ALA ALA ALA VAL LEU PHE ARG MET SER GLU ASP LYS SEQRES 42 B 538 PRO GLN ASP TYR LYS SEQRES 1 C 15 LEU ASP THR PRO ILE ASN TYR SER LEU LYS TYR SER ASP SEQRES 2 C 15 GLU GLN SEQRES 1 D 15 LEU ASP THR PRO ILE ASN TYR SER LEU LYS TYR SER ASP SEQRES 2 D 15 GLU GLN
HET GOL B 672 6
HETNAM GOL GLYCEROL
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 5 GOL C3 H8 O3 FORMUL 6 HOH *72(H2 O)
HELIX 1 1 ARG A 151 LEU A 160 1 10 HELIX 2 2 ASP A 164 SER A 179 1 16 HELIX 3 3 LYS A 181 ARG A 190 1 10 HELIX 4 4 GLN A 193 THR A 205 1 13 HELIX 5 5 ASP A 207 SER A 222 1 16 HELIX 6 6 HIS A 224 SER A 234 1 11 HELIX 7 7 GLY A 236 MET A 243 1 8 HELIX 8 8 LEU A 244 SER A 246 5 3 HELIX 9 9 VAL A 248 GLN A 266 1 19 HELIX 10 10 GLY A 268 ALA A 276 1 9 HELIX 11 11 GLY A 277 LEU A 285 1 9 HELIX 12 12 LEU A 286 LYS A 288 5 3 HELIX 13 13 ASN A 290 TYR A 306 1 17 HELIX 14 14 ASN A 308 SER A 318 1 11 HELIX 15 15 GLY A 320 ARG A 329 1 10 HELIX 16 16 TYR A 333 VAL A 349 1 17 HELIX 17 17 LYS A 354 GLY A 361 1 8 HELIX 18 18 GLY A 361 LEU A 368 1 8 HELIX 19 19 SER A 374 SER A 389 1 16 HELIX 20 20 ASP A 390 ALA A 392 5 3 HELIX 21 21 GLY A 400 LEU A 408 1 9 HELIX 22 22 ASP A 413 LEU A 427 1 15 HELIX 23 23 ASN A 431 VAL A 441 1 11 HELIX 24 24 GLY A 442 GLY A 455 1 14 HELIX 25 25 ARG A 457 THR A 472 1 16 HELIX 26 26 GLU A 477 HIS A 488 1 12 HELIX 27 27 GLY A 490 LEU A 497 1 8 HELIX 28 28 HIS A 503 ALA A 518 1 16 HELIX 29 29 LEU A 519 ALA A 522 5 4 HELIX 30 30 ASN A 523 GLY A 531 1 9 HELIX 31 31 ALA A 532 ASP A 546 1 15 HELIX 32 32 ARG A 565 ALA A 581 1 17 HELIX 33 33 ASP A 583 GLY A 592 1 10 HELIX 34 34 THR A 595 LEU A 602 1 8 HELIX 35 35 LEU A 603 SER A 605 5 3 HELIX 36 36 ILE A 607 ALA A 622 1 16 HELIX 37 37 ASP A 624 GLU A 634 1 11 HELIX 38 38 ALA A 636 LEU A 643 1 8 HELIX 39 39 LEU A 644 SER A 646 5 3 HELIX 40 40 ASN A 648 MET A 662 1 15 HELIX 41 41 ALA B 152 ASN B 161 1 10 HELIX 42 42 VAL B 166 SER B 179 1 14 HELIX 43 43 ALA B 183 ARG B 190 1 8 HELIX 44 44 GLN B 193 THR B 205 1 13 HELIX 45 45 ASP B 207 SER B 222 1 16 HELIX 46 46 HIS B 224 SER B 234 1 11 HELIX 47 47 GLY B 236 MET B 243 1 8 HELIX 48 48 LEU B 244 SER B 246 5 3 HELIX 49 49 VAL B 248 GLN B 266 1 19 HELIX 50 50 GLY B 268 GLY B 277 1 10 HELIX 51 51 GLY B 277 LEU B 285 1 9 HELIX 52 52 ASN B 290 TYR B 306 1 17 HELIX 53 53 ASN B 308 SER B 318 1 11 HELIX 54 54 GLY B 320 ARG B 329 1 10 HELIX 55 55 TYR B 333 VAL B 343 1 11 HELIX 56 56 VAL B 343 SER B 348 1 6 HELIX 57 57 LYS B 354 GLY B 361 1 8 HELIX 58 58 GLY B 361 LEU B 368 1 8 HELIX 59 59 SER B 374 SER B 389 1 16 HELIX 60 60 ASP B 390 ALA B 392 5 3 HELIX 61 61 GLY B 400 LEU B 409 1 10 HELIX 62 62 ASP B 413 LEU B 427 1 15 HELIX 63 63 TYR B 432 VAL B 441 1 10 HELIX 64 64 GLY B 442 GLY B 455 1 14 HELIX 65 65 ARG B 457 THR B 472 1 16 HELIX 66 66 GLU B 477 HIS B 488 1 12 HELIX 67 67 GLY B 490 LEU B 497 1 8 HELIX 68 68 HIS B 503 ALA B 518 1 16 HELIX 69 69 LEU B 519 ALA B 522 5 4 HELIX 70 70 ASN B 523 GLN B 530 1 8 HELIX 71 71 ALA B 532 GLN B 545 1 14 HELIX 72 72 ARG B 565 ALA B 581 1 17 HELIX 73 73 ASP B 583 GLY B 592 1 10 HELIX 74 74 THR B 595 LEU B 602 1 8 HELIX 75 75 LEU B 603 SER B 605 5 3 HELIX 76 76 ILE B 607 ALA B 622 1 16 HELIX 77 77 ASP B 624 GLU B 634 1 11 HELIX 78 78 ALA B 636 LEU B 643 1 8 HELIX 79 79 LEU B 644 SER B 646 5 3 HELIX 80 80 ASN B 648 MET B 662 1 15 HELIX 81 81 ASN D 1026 TYR D 1031 1 6
CISPEP 1 PRO A 500 PRO A 501 0 -0.20 CISPEP 2 PRO B 500 PRO B 501 0 1.37
SITE 1 AC1 7 GLU A 182 ARG A 185 HIS A 186 HIS A 224 SITE 2 AC1 7 GLU B 267 GLY B 268 LYS B 270
CRYST1 51.090 69.255 95.099 68.70 87.04 85.32 P 1 2
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019573 -0.001602 -0.000464 0.00000
SCALE2 0.000000 0.014488 -0.005602 0.00000
SCALE3 0.000000 0.000000 0.011289 0.00000